• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

New hope for targeted treatment of obstructive hypertrophic cardiomyopathy: comment on the EXPLORER-HCM trial.

作者信息

Galiuto Leonarda, Patrono Carlo

机构信息

Department of Cardiology, Fondazione Policlinico A.Gemelli-IRCSS, Catholic University of the Sacred Heart, Policlinico A. Gemelli, Largo A. Gemelli 8, Rome, Italy.

Adjunct Professor of Pharmacology, Catholic University, School of Medicine, Italy and Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.

出版信息

Eur Heart J. 2020 Nov 7;41(42):4089-4090. doi: 10.1093/eurheartj/ehaa801.

DOI:10.1093/eurheartj/ehaa801
PMID:33099599
Abstract
摘要

相似文献

1
New hope for targeted treatment of obstructive hypertrophic cardiomyopathy: comment on the EXPLORER-HCM trial.梗阻性肥厚型心肌病靶向治疗的新希望：评EXPLORER-HCM试验
Eur Heart J. 2020 Nov 7;41(42):4089-4090. doi: 10.1093/eurheartj/ehaa801.
2
Study Design and Rationale of EXPLORER-HCM: Evaluation of Mavacamten in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy.EXPLORER-HCM 研究的设计和原理：评价马卡坦特治疗有症状梗阻性肥厚型心肌病成人患者的疗效。
Circ Heart Fail. 2020 Jun;13(6):e006853. doi: 10.1161/CIRCHEARTFAILURE.120.006853. Epub 2020 Jun 5.
3
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.马卡丹特治疗有症状梗阻性肥厚型心肌病（EXPLORER-HCM）：一项随机、双盲、安慰剂对照、3 期临床试验的健康状况分析。
Lancet. 2021 Jun 26;397(10293):2467-2475. doi: 10.1016/S0140-6736(21)00763-7. Epub 2021 May 15.
4
Mavacamten Favorably Impacts Cardiac Structure in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM Cardiac Magnetic Resonance Substudy Analysis.马伐卡坦对梗阻性肥厚型心肌病的心脏结构有积极影响：EXPLORER-HCM心脏磁共振亚研究分析。
Circulation. 2021 Feb 9;143(6):606-608. doi: 10.1161/CIRCULATIONAHA.120.052359. Epub 2020 Nov 15.
5
A plain language summary of the EXPLORER-HCM study: mavacamten for obstructive hypertrophic cardiomyopathy.EXPLORER-HCM 研究的通俗易懂总结：mavacamten 治疗梗阻性肥厚型心肌病。
Future Cardiol. 2021 Oct;17(7):1269-1275. doi: 10.2217/fca-2021-0044. Epub 2021 May 21.
6
Projecting the Long-term Clinical Value of Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy in the United States: An Assessment of Net Health Benefit.预测美伐他汀治疗美国梗阻性肥厚型心肌病的长期临床价值：净健康效益评估。
Clin Ther. 2022 Jan;44(1):52-66.e2. doi: 10.1016/j.clinthera.2021.11.006. Epub 2021 Dec 12.
7
The end of the beginning for drug therapy in obstructive hypertrophic cardiomyopathy with EXPLORER-HCM.EXPLORER-HCM研究开启梗阻性肥厚型心肌病药物治疗新篇章。
Cardiovasc Res. 2020 Nov 1;116(13):e175-e178. doi: 10.1093/cvr/cvaa282.
8
[EXPLORER-HCM: mavacamten for the treatment of symptomatic obstructive hypertrophic cardiomyopathy].[探索者-HCM：mavacamten用于治疗有症状的梗阻性肥厚型心肌病]
G Ital Cardiol (Rome). 2021 Jan;22(1):30-32. doi: 10.1714/3502.34878.
9
[Mavacamten - the first disease-specific pharmacological treatment of hypertrophic cardiomyopathy].[麦卡姆坦——肥厚型心肌病的首个疾病特异性药物治疗]
Lakartidningen. 2021 Aug 5;118:21054.
10
Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy.肌球蛋白抑制剂 Mavacamten 治疗梗阻性肥厚型心肌病的新策略
Curr Cardiol Rep. 2021 Jun 3;23(7):79. doi: 10.1007/s11886-021-01508-0.